We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Actinium Pharmaceuticals, Inc. Licenses Monoclonal Antibody

News   Jul 12, 2012

 
Actinium Pharmaceuticals, Inc. Licenses Monoclonal Antibody
 
 
 

RELATED ARTICLES

Preventing the Spread of Certain Cancers

News

Scientists have taken an important step towards the development of an agent against the metastasis of certain cancers.

READ MORE

HIV Resistance Promoted by Repeated Semen Exposure

News

Contrary to the long-held view that semen can only act as a way to transmit HIV-1 from men to women, scientists found that frequent and sustained semen exposure can change the characteristics of the circulating and vaginal tissue immune cells that are targets for infection, reducing the susceptibility to a future infection.

READ MORE

Slow Electrons Destroy Cancer Cell DNA

News

Ion therapy harnesses complex atomic effects to destroy cancer cells. Researchers have now discovered a mechanism which makes this process considerably easier.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE